Intraoperative Radiotherapy - Publications - Faculty & Research

September 2012
Supplement

Intraoperative Radiotherapy for Breast Cancer (B)

The intraoperative radiotherapy (IORT) business at Carl Zeiss Meditec had struggled with growth since the time of the (A) case. Though the unit had grown revenues in excess of 50% and had exceeded its EBIT target, it faced several key strategic choices. Should it... View Details

Keywords: Radiotherapy; Breast Cancer; Brachytherapy; Therapeutic Radiation; Oncology; Oncology Treatment Systems; Elekta AB; Varian Medical Systems; Xoft; Electronic Brachytherapy; Intraoperative Radiotherapy; Disruptive Innovation; Health Care and Treatment; Entrepreneurship; Technological Innovation; Growth and Development Strategy; Health Industry; Germany

Citation

Purchase

July 2011 (Revised September 2012)
Case

Intraoperative Radiotherapy for Breast Cancer (A)

By: Willy Shih

"This trial is going to take longer." Those were words that Michael Kaschke, CEO of Carl Zeiss AG, was not surprised to hear as he nurtured the intraoperative radiotherapy business inside his company's microsurgery unit. But he also didn't expect it to take 13 years to... View Details

Keywords: Finance; Business History; Disruptive Innovation; Emerging Markets; Organizational Change and Adaptation; Research and Development; Safety

Citation

Educators

Purchase

11 Dec 2012
First Look

First Look: Dec. 11

that lie ahead. Purchase this supplement:http://hbr.org/search/613041-PDF-ENG Intraoperative Radiotherapy for Breast Cancer (B) Shih, WillyHarvard Business School Supplement 613-040 The View Details

Keywords: Sean Silverthorne

20 Sep 2011
First Look

First Look: September 20

for decades. Purchase this case:http://cb.hbsp.harvard.edu/cb/product/311130-PDF-ENG Intraoperative Radiotherapy for Breast Cancer Willy ShihHarvard Business School Case 612-003 "This trial is going to... View Details